Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genus PLC Share Issue/Capital Change 2019

Feb 1, 2019

4873_rns_2019-02-01_2e8a4d31-9dcb-4a09-a3f1-5a71da244cfa.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8279O

Genus PLC

01 February 2019

Genus plc

1 February 2019

BLOCK LISTING SIX MONTHLY RETURN

To: FCA

1. Name of company

Genus plc

2. Name of schemes

Genus plc 2004 Executive Share Option Plan

3. Period of return:

From 01.08.18 to 31.01.19

4. Balance of unallotted securities under scheme from previous return

Genus plc 2004 Executive Share Option Plan 57,122
TOTAL BALANCE 57,122

5.  Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for)

Genus plc 2004 Executive Share Option Plan 0
TOTAL BALANCE 0

6.  Less: Number of securities issued/allotted under scheme during period

Genus plc 2004 Executive Share Option Plan 6,038
TOTAL BALANCE 6,038

7.  Equals: Balance under scheme not yet issued/allotted at end of period 

Genus plc 2004 Executive Share Option Plan 51,084
TOTAL BALANCE 51,084

Name of contact: Vaughn Walton, Interim Deputy Company Secretary

Address of contact:

Matrix House

Basing View

Basingstoke

Hampshire

RG21 4DZ

Telephone number of contact: 01256 347100

Signed by Dan Hartley

Group General Counsel & Company Secretary for and on behalf of

Name of applicant: Genus plc

If you knowingly or recklessly give false or misleading information you may be liable to prosecution.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRSSFFSFFUSESE